|
US6071970A
(en)
*
|
1993-02-08 |
2000-06-06 |
Nps Pharmaceuticals, Inc. |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
|
|
US6017965A
(en)
*
|
1993-02-08 |
2000-01-25 |
Nps Pharmaceuticals, Inc. |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
|
|
US6211245B1
(en)
|
1993-02-08 |
2001-04-03 |
Nps Pharmaceuticals, Inc. |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
|
|
US6750244B2
(en)
|
1993-02-08 |
2004-06-15 |
Nps Pharmaceuticals, Inc. |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
|
|
US7087765B2
(en)
|
1995-06-07 |
2006-08-08 |
Nps Pharmaceuticals, Inc. |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
|
|
DE4426245A1
(de)
*
|
1994-07-23 |
1996-02-22 |
Gruenenthal Gmbh |
1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
|
|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
|
US6262115B1
(en)
*
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
|
JP2002511835A
(ja)
*
|
1996-06-07 |
2002-04-16 |
エヌピーエス・ファーマシウティカルズ・インコーポレイテッド |
神経障害および神経病の治療に有用な受容体作動性カルシウムチャネル上の新規部位で活性な化合物
|
|
JP2000516210A
(ja)
|
1996-07-12 |
2000-12-05 |
ロイコサイト，インコーポレーテッド |
ケモカインレセプターアンタゴニストとその使用方法
|
|
WO1998056752A1
(en)
*
|
1997-06-11 |
1998-12-17 |
Nps Pharmaceuticals, Inc. |
Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
|
|
US6679859B1
(en)
|
1997-10-24 |
2004-01-20 |
Alliance Pharmaceutical Corp. |
Amelioration of ischemic damage using synthetic oxygen carriers
|
|
AU6109698A
(en)
*
|
1998-02-20 |
1999-09-06 |
Zeneca Limited |
Analgesic peptides from venom of (grammostola spatulata) and use thereof
|
|
EP0957073A1
(en)
|
1998-05-12 |
1999-11-17 |
Schwarz Pharma Ag |
Novel derivatives of 3,3-diphenylpropylamines
|
|
AU771252B2
(en)
*
|
1998-07-13 |
2004-03-18 |
Nps Pharmaceuticals, Inc. |
Methods and compounds for treating depression and other disorders
|
|
IT1304874B1
(it)
*
|
1998-07-17 |
2001-04-05 |
Univ Firenze |
Amminoalcoli,amminochetoni e loro derivati,loro preparazione ed usocome farmaci per le patologie del sistema nervoso centrale (snc) e
|
|
AU760889B2
(en)
|
1998-10-14 |
2003-05-22 |
Ortho-Mcneil Pharmaceutical, Inc. |
1,2-disubstituted cyclopropanes
|
|
GB9907965D0
(en)
|
1999-04-09 |
1999-06-02 |
Glaxo Group Ltd |
Medical use
|
|
US7345019B1
(en)
*
|
1999-04-13 |
2008-03-18 |
The Kenneth S. Warren Institute, Inc. |
Modulation of excitable tissue function by peripherally administered erythropoietin
|
|
EP1207882A4
(en)
*
|
1999-07-30 |
2003-03-19 |
Vertex Pharma |
DERIVATIVES OF ACYCLIC AND CYCLIC AMINES
|
|
US6548522B1
(en)
*
|
1999-10-12 |
2003-04-15 |
Hoffmann-La Roche Inc. |
Method for treating conditions related to the glutamate receptor using carboxylic acid amide derivatives
|
|
AU2006236018B2
(en)
*
|
2000-08-08 |
2009-10-01 |
Minas Theodore Coroneo |
Methods for preventing pressure induced apoptotic neural cell death
|
|
AUPQ926700A0
(en)
*
|
2000-08-08 |
2000-08-31 |
Coroneo, Minas Theodore |
Methods for preventing pressure induced apoptotic neural cell death
|
|
US20030072737A1
(en)
*
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
|
US7767643B2
(en)
|
2000-12-29 |
2010-08-03 |
The Kenneth S. Warren Institute, Inc. |
Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
|
|
US20030005476A1
(en)
*
|
2001-03-29 |
2003-01-02 |
Allen Keith D. |
Delta opioid receptor disruptions, compositions and methods related thereto
|
|
US20060112439A1
(en)
*
|
2001-03-29 |
2006-05-25 |
Allen Keith D |
Delta opioid receptor disruptions, compositions and methods related thereto
|
|
US6649607B2
(en)
|
2001-05-18 |
2003-11-18 |
Vela Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing convulsions or seizures
|
|
CA2457011C
(en)
*
|
2001-08-20 |
2012-04-24 |
Maiken Nedergaard |
Treatment of glial tumors with glutamate antagonists
|
|
EP1298581A1
(fr)
*
|
2001-09-27 |
2003-04-02 |
C.S.E.M. Centre Suisse D'electronique Et De Microtechnique Sa |
Procédé et dispositif pour calculer les valeurs des neurones d'un réseau neuronal
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
MXPA05000063A
(es)
*
|
2002-07-01 |
2005-04-08 |
Kenneth S Warren Inst Inc |
Citocinas recombinantes protectoras de tejido y acidos nucleicos que las codifican para la proteccion, restauracion y mejora de celulas, tejidos y organos respondedores.
|
|
US20040082543A1
(en)
*
|
2002-10-29 |
2004-04-29 |
Pharmacia Corporation |
Compositions of cyclooxygenase-2 selective inhibitors and NMDA receptor antagonists for the treatment or prevention of neuropathic pain
|
|
DE10315917A1
(de)
|
2003-04-08 |
2004-11-18 |
Schwarz Pharma Ag |
Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
|
|
CA2522888C
(en)
*
|
2003-05-23 |
2012-07-17 |
Bridge Pharma, Inc. |
Smooth muscle spasmolytic agents
|
|
GB0313612D0
(en)
*
|
2003-06-12 |
2003-07-16 |
Novartis Ag |
Organic compounds
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
CN1897959A
(zh)
*
|
2003-09-29 |
2007-01-17 |
沃伦药品公司 |
用于治疗和预防脓毒病和粘连形成的组织保护细胞因子
|
|
CA2546077C
(en)
*
|
2003-11-12 |
2016-07-05 |
Yeda Research And Development Co. Ltd. |
Vaccine and method for treatment of neurodegenerative diseases
|
|
EP1737809B1
(en)
|
2004-02-27 |
2013-09-18 |
Amgen, Inc |
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
|
|
MXPA06013270A
(es)
*
|
2004-05-14 |
2007-04-23 |
Johnson & Johnson |
Compuestos de opioide carboxamido.
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
CA2576191C
(en)
|
2004-08-20 |
2013-03-19 |
University Of Virginia Patent Foundation |
T type calcium channel inhibitors
|
|
US10583094B2
(en)
*
|
2004-09-18 |
2020-03-10 |
University Of Maryland |
Therapeutic methods that target the NCCA-ATP channel
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
JP2009523705A
(ja)
|
2005-11-30 |
2009-06-25 |
エフ．ホフマン−ラ ロシュ アーゲー |
３−アミノ−１−アリールプロピルインドールの合成方法
|
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
CA2693369A1
(en)
*
|
2007-07-17 |
2009-01-22 |
Allergan, Inc. |
Methods for treating anxiety
|
|
AR070950A1
(es)
*
|
2007-11-01 |
2010-05-19 |
Acucela Inc |
Compuestos derivados de amina, composiciones farmaceuticas de ellos, compuestos inhibidores de produccion de 11-cis-retinol y metodos para tratar enfermedades y trastornos oftalmicos
|
|
TWI454288B
(zh)
|
2008-01-25 |
2014-10-01 |
Gruenenthal Chemie |
藥物劑型
|
|
ES2599031T3
(es)
|
2008-05-09 |
2017-01-31 |
Grünenthal GmbH |
Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización
|
|
WO2010093070A1
(ko)
*
|
2009-02-12 |
2010-08-19 |
서울대학교산학협력단 |
Glur2-결손 ampar 길항제를 포함하는 정신 질환 예방 또는 치료용 약학 조성물
|
|
CN101838235B
(zh)
*
|
2009-06-12 |
2013-08-07 |
重庆华邦制药有限公司 |
3-苯基-3＇-吡啶基丙烯胺类化合物及其合成方法
|
|
ES2534908T3
(es)
|
2009-07-22 |
2015-04-30 |
Grünenthal GmbH |
Forma de dosificación de liberación controlada extruida por fusión en caliente
|
|
BR112012001466A2
(pt)
|
2009-07-22 |
2020-08-11 |
Grünenthal GmbH |
forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem
|
|
CA2808219C
(en)
|
2010-09-02 |
2019-05-14 |
Gruenenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
|
WO2012028318A1
(en)
|
2010-09-02 |
2012-03-08 |
Grünenthal GmbH |
Tamper resistant dosage form comprising an anionic polymer
|
|
JP6063462B2
(ja)
|
2011-07-29 |
2017-01-18 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
即時薬剤放出を提供するタンパーレジスタント錠剤
|
|
BR112014002022A2
(pt)
|
2011-07-29 |
2017-02-21 |
Gruenenthal Gmbh |
comprimido resistente à violação proporcionando liberação de fármaco imediata
|
|
BR112014019988A8
(pt)
|
2012-02-28 |
2017-07-11 |
Gruenenthal Gmbh |
Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico
|
|
LT2838512T
(lt)
|
2012-04-18 |
2018-11-12 |
GrĆ¼nenthal GmbH |
Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
MX2015016254A
(es)
|
2013-05-29 |
2016-04-20 |
Gruenenthal Gmbh |
Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
|
|
AU2014273227B2
(en)
|
2013-05-29 |
2019-08-15 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|
|
AU2014289187B2
(en)
|
2013-07-12 |
2019-07-11 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
|
HK1224189A1
(zh)
|
2013-11-26 |
2017-08-18 |
Grünenthal GmbH |
通过低温研磨制备粉状药物组合物
|
|
WO2015173195A1
(en)
|
2014-05-12 |
2015-11-19 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
|
US9872835B2
(en)
|
2014-05-26 |
2018-01-23 |
Grünenthal GmbH |
Multiparticles safeguarded against ethanolic dose-dumping
|
|
WO2016170097A1
(en)
|
2015-04-24 |
2016-10-27 |
Grünenthal GmbH |
Tamper-resistant dosage form with immediate release and resistance against solvent extraction
|
|
CA2986891C
(en)
|
2015-05-26 |
2022-01-04 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Compositions for use in treating parkinson's disease and related disorders
|
|
CA2998259A1
(en)
|
2015-09-10 |
2017-03-16 |
Grunenthal Gmbh |
Protecting oral overdose with abuse deterrent immediate release formulations
|
|
CN107311891B
(zh)
*
|
2017-06-08 |
2019-08-06 |
山东一航新材料科技有限公司 |
一种亚胺类除水剂的制备方法
|
|
US11466027B2
(en)
|
2019-07-03 |
2022-10-11 |
H. Lundbeck A/S |
Modulators of the NMDA receptor
|
|
US11358971B2
(en)
|
2019-07-03 |
2022-06-14 |
H. Lundbeck A/S |
Prodrugs of modulators of the NMDA receptor
|
|
JP7880815B2
(ja)
*
|
2019-10-01 |
2026-06-26 |
メモリアル スローン－ケタリング キャンサー センター |
Ｉｄタンパク質の小分子阻害剤
|
|
CA3217559A1
(en)
*
|
2021-05-05 |
2022-11-10 |
Kamaluddin Abdur-Rashid |
Catalytic tryptamine processes and precursors
|